An interventional study of Scaffolding-Based Board Game Intervention in Schizophrenia, sponsored by Kaohsiung Kai-Suan Psychiatric Hospital. Not yet recruiting at 1 site in Taiwan. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2026-09-11.
Sponsored by Kaohsiung Kai-Suan Psychiatric Hospital · Not applicable, Interventional, and Treatment
This study aims to evaluate the effects of a scaffolding-based board game intervention on cognitive and functional outcomes in older adults with schizophrenia living in psychiatric nursing homes. Participants will be assigned by clusters to either an intervention group or a control group. The intervention group will receive a 12-week board game training program, while the control group will receive usual care. Cognitive and functional outcomes will be assessed before the intervention, immediately after the 12-week intervention, and three months after the intervention. The study will examine whether the board game intervention can improve cognitive and daily functioning in older adults with schizophrenia.
Exclusion Criteria:
Behavioral: Scaffolding-Based Board Game Intervention
Participants will receive a scaffolding-based board game intervention once weekly for 12 weeks, with each session lasting approximately 60 minutes.
Cognitive Function Assessed by MoCA-TW 7.1
The Montreal Cognitive Assessment-Taiwan Version 7.1 (MoCA-TW 7.1) is used to assess global cognitive function. The total score ranges from 0 to 30, with higher scores indicating better cognitive function.
Time frame: Baseline, immediately after the 12-week intervention, and 3 months after completion of the intervention
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kaohsiung Kai-Suan Psychiatric Hospital